Abstract | AIM: METHODS: The pCR3.1/GR plasmid, which expresses gastrin receptor, cholecystokinin-2 receptor (CCK-2R), was transfected into a colonic cancer cell line Colo320 by Lipofectamine (TM)2000 and the stably expressing CCK-2R clones were screened by G418. The expression levels of gastrin receptor in the Colo320 and the transfected Colo320WT cell line were assayed by RT-PCR. Colo320WT cells were treated with G17 in a time-dependent manner (0, 1, 6, 12, 24 and 48 h), then with L365,260 ( Gastrin(17) receptor blocker) for 30 min, and with G17 again for 12 h or L365,260 for 12 h. Expression levels of beta-catenin in a TX-100 soluble fraction and TX-100 insoluble fraction of Colo320WT cells treated with G17 were detected by co-immuniprecipation and Western blot. Immunocytochemistry was used to examine the distribution of beta-catenin in CoLoWT320 cells. Expression levels of c-myc and cyclin D1 in Colo320WT cells treated with G17 were assayed by Western blot. RESULTS: Expression levels of beta-catenin in the TX-100 solution fraction decreased apparently in a time-dependent fashion and reached the highest level after G17 treatment for 12 h, while expression levels of beta-catenin in the TX-100 insoluble fraction were just on the contrary. Immunocytochemistry showed that beta-catenin was translocated from the cell membranes into the cytoplasm and nucleus under G17 treatment. Expression levels of c-myc and cyclin D1 in the G17-treated Colo320WT cells were markedly higher compared to the untreated Colo320WT cells. In addition, the aforementioned G17-stimulated responses were blocked by L365,260. CONCLUSION: Gastrin17 activates beta-catenin/Tcf-4 signaling in Colo320WT cells, thereby leading to over-expression of c-myc and cyclin D1.
|
Authors | Jun Cao, Jie-Ping Yu, Chao-Hong Liu, Lan Zhou, Hong-Gang Yu |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 12
Issue 46
Pg. 7482-7
(Dec 14 2006)
ISSN: 1007-9327 [Print] United States |
PMID | 17167838
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CTNNB1 protein, human
- Cyclin D
- Cyclins
- DNA, Complementary
- Gastrins
- MYC protein, human
- Proto-Oncogene Proteins c-myc
- Receptor, Cholecystokinin B
- Recombinant Proteins
- TCF Transcription Factors
- TCF7L2 protein, human
- Transcription Factor 7-Like 2 Protein
- beta Catenin
- gastrin 17
|
Topics |
- Base Sequence
- Cell Line, Tumor
- Colonic Neoplasms
(drug therapy, genetics, metabolism)
- Cyclin D
- Cyclins
(metabolism)
- DNA, Complementary
(genetics)
- Gastrins
(pharmacology)
- Humans
- Proto-Oncogene Proteins c-myc
(metabolism)
- Receptor, Cholecystokinin B
(genetics, metabolism)
- Recombinant Proteins
(genetics, metabolism)
- TCF Transcription Factors
(metabolism)
- Transcription Factor 7-Like 2 Protein
- Transfection
- beta Catenin
(metabolism)
|